Special Issue: GLP-1 agonists in Parkinson’s disease: New evidence, new questions?
MDS Podcast
00:00
Enhancing Clinical Trials for Parkinson's Disease
This chapter explores advancements in clinical trials for Parkinson's disease, highlighting a new platform trial designed to test multiple agents against a shared placebo. The discussion emphasizes optimism for improved treatment identification and the necessity of ongoing research to refine trial designs for targeted therapies.
Transcript
Play full episode
